Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

PIQUR Therapeutics AG - Product Pipeline Review - 2015

Published: Feb-2015 | Format: PDF | Global Markets Direct | Number of pages: 28 | Code: MRS - 7039

 

Global Markets Direct’s, ‘PIQUR Therapeutics AG Product Pipeline Review 2015’, provides an overview of the PIQUR Therapeutics AG’s pharmaceutical research and development focus.

 

This report provides comprehensive information on the current therapeutic developmental pipeline of PIQUR Therapeutics AG’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

 

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

 

Scope

 

The report provides brief overview of PIQUR Therapeutics AG including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of PIQUR Therapeutics AG’s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement 
Latest news and deals relating to the PIQUR Therapeutics AG’s pipeline products

 

Reasons to buy

 

Evaluate PIQUR Therapeutics AG’s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of PIQUR Therapeutics AG in its therapy areas of focus
Identify new drug targets and therapeutic classes in the PIQUR Therapeutics AG’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of PIQUR Therapeutics AG and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of PIQUR Therapeutics AG
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of PIQUR Therapeutics AG and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table of Contents
 

 

Table of Contents 2
List of Tables 4
List of Figures 4
PIQUR Therapeutics AG Snapshot 5
PIQUR Therapeutics AG Overview 5
Key Information 5
Key Facts 5
PIQUR Therapeutics AG - Research and Development Overview 6
Key Therapeutic Areas 6
PIQUR Therapeutics AG - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
PIQUR Therapeutics AG - Pipeline Products Glance 10
PIQUR Therapeutics AG - Clinical Stage Pipeline Products 10
Phase I Products/Combination Treatment Modalities 10
PIQUR Therapeutics AG - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
PIQUR Therapeutics AG - Drug Profiles 13
PQR-309 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
PQR-401 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
PQR-5XX 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
PQR-6XX 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
PQR-311 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
PQR-316 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Small Molecules for Undisclosed Indication 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
PIQUR Therapeutics AG - Pipeline Analysis 20
PIQUR Therapeutics AG - Pipeline Products by Target 20
PIQUR Therapeutics AG - Pipeline Products by Route of Administration 21
PIQUR Therapeutics AG - Pipeline Products by Molecule Type 22
PIQUR Therapeutics AG - Pipeline Products by Mechanism of Action 23
PIQUR Therapeutics AG - Recent Pipeline Updates 24
PIQUR Therapeutics AG - Dormant Projects 25
PIQUR Therapeutics AG - Locations And Subsidiaries 26
Head Office 26

 

Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 27
Disclaimer 28


 

List of Tables
 

 

PIQUR Therapeutics AG, Key Information 5
PIQUR Therapeutics AG, Key Facts 5
PIQUR Therapeutics AG - Pipeline by Indication, 2015 7
PIQUR Therapeutics AG - Pipeline by Stage of Development, 2015 8
PIQUR Therapeutics AG - Monotherapy Products in Pipeline, 2015 9
PIQUR Therapeutics AG - Phase I, 2015 10
PIQUR Therapeutics AG - Preclinical, 2015 11
PIQUR Therapeutics AG - Discovery, 2015 12
PIQUR Therapeutics AG - Pipeline by Target, 2015 20
PIQUR Therapeutics AG - Pipeline by Route of Administration, 2015 21
PIQUR Therapeutics AG - Pipeline by Molecule Type, 2015 22
PIQUR Therapeutics AG - Pipeline Products by Mechanism of Action, 2015 23
PIQUR Therapeutics AG - Recent Pipeline Updates, 2015 24
PIQUR Therapeutics AG - Dormant Developmental Projects,2015 25

 

List of Figures
 

PIQUR Therapeutics AG - Pipeline by Top 10 Indication, 2015 7
PIQUR Therapeutics AG - Pipeline by Stage of Development, 2015 8
PIQUR Therapeutics AG - Monotherapy Products in Pipeline, 2015 9
PIQUR Therapeutics AG - Pipeline by Top 10 Target, 2015 20
PIQUR Therapeutics AG - Pipeline by Top 10 Molecule Type, 2015 22
PIQUR Therapeutics AG - Pipeline Products by Top 10 Mechanism of Action, 2015 23

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing